Company Profile

Augusta Pharmaceuticals Inc
Profile last edited on: 1/3/17      CAGE: 5QKM4      UEI: GNV6VN6F4JA5

Business Identifier: Gene-therapy for cancer
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

58 Oak Cliff Road
Newton, MA 02460
   (617) 965-9079
Location: Single
Congr. District: 04
County: Middlesex

Public Profile

Augusta Pharmaceuticals works in researching genetic technologies for application in cancer therapeutics. The company has used cutting edge genetic technologies and shRNA screening methodologies to uncover the ROS receptor tyrosine kinase as a cancer survival gene.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2010 1 NIH $203,208
Project Title: Tas::75 0849::Tas Development of Ros Kinase Inhibitors - Phase I SBIR Topic 255

Key People / Management

  Dorre A Grueneberg -- President

Company News

There are no news available.